[Treatment of chronic bacterial prostatitis by perfusion with double-balloon and triple-channel catheter: a control study].
OBJECTIVE
To investigate the efficacy of the double-balloon and triple-channel catheter (DBTC) in the treatment of chronic bacterial prostatitis (CBP).


METHODS
One hundred and three CBP patients were randomly assigned to three different groups and received three different therapies, respectively: 1. 61 cases by transurethral perfusion and drainage with antibiotics with DBTC catheter; 2. 29 cases by intravenous antibiotics, and 3. 13 cases by transurethral irrigation with 0.9% saline. The lecithin, white blood cells (WBC) in expressed prostatic secretion (EPS) and Meares-Stamey's test fractionary urine culture pre- and post-therapies were compared.


RESULTS
The improvement rates of clinical symptoms and lecithin corpuscles were 81.9% and 68.9%, respectively. And the decline rate of WBC and bacteriological efficacy rate were 75.4% and 91.8%, respectively. There was a significant statistical difference between the DBTC group and the intravenous group in the lecithin, WBC and bacterial culture (P < 0.05, < 0.01 and < 0.01, respectively), and so was there between the saline group and the intravenous group in the decline of WBC(chi 2 = 5.6, P < 0.05), but with no difference in lecithin and bacterial culture. Among 61 patients treated with DBTC, 3 developed mild allergic reaction in urethra.


CONCLUSIONS
Transurethral DBTC has a better clinical efficacy than traditional intravenous treatment for CBP. DBTC perfusion combined with other hypurgia holds obvious advantages of being safe, effective, easy and repeatable in the treatment of CBP.
Huang
Wei-Dong
WD
Xinjiang Jiayin Andrology Hospital, Urumuqi, Xinjiang 830011, China.
Huang
Wen-Jie
WJ
Liu
Pei
P
Ren
Wei
W
Xu
Bing
B
Wang
Xing-Jun
XJ
D000293:Adolescent; D000328:Adult; D001424:Bacterial Infections / Q000150:complications / Q000628:therapy*; D002404:Catheterization / Q000379:methods*; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D010477:Perfusion / Q000379:methods*; D011467:Prostate / Q000382:microbiology; D011472:Prostatitis / Q000382:microbiology / Q000628:therapy*